State Street Corp. Amends Caribou Biosciences Stake Filing
Ticker: CRBU · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street Corp. updated its Caribou Biosciences holding, confirming continued passive investment.**
AI Summary
State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 25, 2024, indicating its ownership of Caribou Biosciences Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, confirming their continued passive investment in the biotech company. For investors, this means a significant institutional holder maintains its position, which can be seen as a vote of confidence in Caribou Biosciences' long-term prospects.
Why It Matters
This filing confirms State Street Corporation's ongoing passive investment in Caribou Biosciences, signaling continued institutional interest in the company's stock.
Risk Assessment
Risk Level: low — This is a routine amendment by a passive institutional investor, indicating no immediate change in investment strategy or significant risk.
Analyst Insight
Investors should note that a major institutional investor, State Street Corporation, continues to hold a position in Caribou Biosciences, which can be a positive signal, but this filing itself doesn't indicate any new buying or selling activity, so further research into the company's fundamentals is warranted.
Key Numbers
- 142038108 — CUSIP Number (Identifies Caribou Biosciences Inc. common stock)
- 005-92726 — SEC File Number (Unique identifier for Caribou Biosciences' SEC registration)
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Caribou Biosciences, Inc. (company) — the subject company whose stock is being reported
- 0000093751-24-000191 (dollar_amount) — accession number for the filing
- January 25, 2024 (date) — date the SC 13G/A filing was made
- December 31, 2023 (date) — date of the event requiring the filing
- 142038108 (dollar_amount) — CUSIP number for Caribou Biosciences common stock
Forward-Looking Statements
- State Street Corporation will maintain its passive investment in Caribou Biosciences Inc. for the foreseeable future. (State Street Corporation) — high confidence, target: 2025-01-25
- Caribou Biosciences Inc. will continue to attract institutional investment due to its biotech sector position. (Caribou Biosciences Inc.) — medium confidence, target: 2024-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to previously reported beneficial ownership of securities.
Who is the 'Reporting Person' in this filing?
The 'Reporting Person' is STATE STREET CORPORATION, identified with IRS Identification No. 04-2456637.
What is the 'Subject Company' or 'Issuer' of the securities?
The 'Subject Company' or 'Issuer' is CARIBOU BIOSCIENCES INC, with the Central Index Key (CIK) 0001619856.
What was the 'Date of Event Which Requires Filing of This Statement'?
The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13D-1 (B), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding Caribou Biosciences, Inc. (CRBU).